C12N 2506/1369
From blood-borne mesenchymal stem cells
Official title: from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood
C12N2506/1369 (From blood-borne mesenchymal stem cells) appears on 44 US grants and 90 published applications in this corpus.
Search patents in C12N- Granted patents
- 44
- Published applications
- 90
- Assignees
- 54
- Inventors
- 164
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 3 |
| 2009 | 0 | 2 |
| 2010 | 2 | 2 |
| 2011 | 1 | 0 |
| 2012 | 3 | 3 |
| 2013 | 0 | 4 |
| 2014 | 4 | 0 |
| 2015 | 0 | 4 |
| 2016 | 0 | 10 |
| 2017 | 2 | 2 |
| 2018 | 9 | 10 |
| 2019 | 2 | 4 |
| 2020 | 5 | 3 |
| 2021 | 3 | 7 |
| 2022 | 3 | 2 |
| 2023 | 4 | 7 |
| 2024 | 0 | 6 |
| 2025 | 4 | 5 |
| 2026 | 0 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Particulate lyophilized platelet lysate compositions2 Dec 2025US 12,486,491 B2Jadi Cell LLC
- Methods and compositions for inducing hematopoietic cell differentiation12 Aug 2025US 12,385,012 B2Fate Therapeutics, Inc.
- Complex for promoting cartilage differentiation comprising cartilage cell-free crush and stem cell and use thereof8 Jul 2025US 12,350,295 B2Kangstem Biotech Co., Ltd.
- Cell differentiation medium composition, high secretion insulin-producing cells and preparation method thereof14 Jan 2025US 12,195,754 B2Gwo Xi Stem Cell Applied Technology Co., Ltd.
- HLA homozygous induced pluripotent stem cell (iPSC) libraries5 Dec 2023US 11,834,757 B2New York Blood Center, Inc.
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Method of differentiating stem cells1 Oct 2026US 2026/0297554 A1
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
- Composition for inducing differentiation of mesenchymal stem cells into adipocytes6 Aug 2026US 2026/0226414 A1Encell Co., Ltd.
- Method of inducing umbilical cord mesenchymal stem cells to differentiate insulin-like cells and an application thereof16 Jul 2026US 2026/0201338 A1
Most cited
By later US patents
- Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells21US 8,287,854 B2Cellresearch Corporation Pte. Ltd. · 2012
- Methods and compositions for inducing hematopoietic cell differentiation17US 10,626,372 B1Fate Therapeutics, Inc. · 2020
- Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom11US 10,066,209 B2Cellresearch Corporation Pte. Ltd. · 2018
- Compositions and methods for modifying cell surface glycans11US 8,084,236 B22011
- Cultures, products and methods using umbilical cord matrix cells9US 7,736,892 B2Kansas State University Research Foundation · 2010